Quanex Building Products Announces First Quarter 2026 Results and Provides Full Year 2026 Guidance
Net Sales Growth of ~2% Year-Over-Year
Healthy Balance Sheet and Strong Liquidity
Well Positioned to Capitalize on Pent-Up Demand
The Company reported the following selected financial results:
| Three Months Ended |
|||
| ($ in millions, except per share data) | 2026 | 2025 | |
| Gross Margin | |||
| Gross Margin % | 24.1% | 23.1% | |
| Net Loss | ( |
( |
|
| Diluted EPS | ( |
( |
|
| Adjusted Net (Loss) Income | ( |
||
| Adjusted Diluted EPS | ( |
||
| Adjusted EBITDA | |||
| Adjusted EBITDA Margin % | 6.7% | 9.6% | |
| Cash Used For Operating Activities | ( |
( |
|
| Free Cash Flow | ( |
( |
|
(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)
“Due to the seasonality of our business, coupled with the longer cash conversion cycle of the legacy Tyman business, we expect to be a net borrower during the first half of our fiscal year, which impacts our leverage ratio. Our balance sheet is healthy, and we will remain focused on prioritizing debt repayment as we generate cash. Looking ahead, we continue to be optimistic about our prospects for profitable growth and value creation.”
First Quarter 2026 Results Summary
Quanex reported net sales of
On a consolidated basis, the decrease in adjusted earnings for the first quarter of 2026 compared to the first quarter of 2025 was mainly due to reduced operating leverage from lower volumes related to ongoing macroeconomic uncertainty coupled with low consumer confidence and higher, but temporary, operational costs related to Quanex’s window and door hardware plant in
Balance Sheet & Liquidity Update
As of
The Company’s liquidity was
Outlook
*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes related to net income. As a result, Quanex is unable to provide forward-looking net income guidance. Investors are cautioned that the Company’s Adjusted EBITDA excludes significant items, including interest expense, income taxes, depreciation and amortization, and the other adjustments described below, and that net income may differ materially from Adjusted EBITDA.
Conference Call and Webcast Information
The Company has also scheduled a conference call for
Participants can pre-register for the conference call using the following link:
https://register-conf.media-server.com/register/BIc6562606fc8b4f93a903be54b98e9c71
Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.
About Quanex
Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.
Non-GAAP Terminology Definitions and Disclaimers
Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.
Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.
Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) (Unaudited) |
|||||||
| Three Months Ended |
|||||||
| 2026 |
2025 |
||||||
| Net sales | $ | 409,089 | $ | 400,044 | |||
| Cost of sales | 310,562 | 307,728 | |||||
| Selling, general and administrative | 71,426 | 66,650 | |||||
| Restructuring charges | - | 7,904 | |||||
| Depreciation and amortization | 24,249 | 24,740 | |||||
| Operating income (loss) | 2,852 | (6,978 | ) | ||||
| Interest expense | (12,367 | ) | (14,186 | ) | |||
| Other, net | 5,617 | 1,229 | |||||
| Loss before income taxes | (3,898 | ) | (19,935 | ) | |||
| Income tax (expense) benefit | (173 | ) | 5,050 | ||||
| Net loss | $ | (4,071 | ) | $ | (14,885 | ) | |
| Loss per common share, basic | $ | (0.09 | ) | $ | (0.32 | ) | |
| Loss per common share, diluted | $ | (0.09 | ) | $ | (0.32 | ) | |
| Weighted average common shares outstanding: | |||||||
| Basic | 45,456 | 47,015 | |||||
| Diluted | 45,456 | 47,015 | |||||
| Cash dividends per share | $ | 0.08 | $ | 0.08 | |||
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) |
|||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 62,311 | $ | 76,018 | |||
| Restricted Cash | 2,332 | 2,100 | |||||
| Accounts receivable, net | 189,243 | 205,384 | |||||
| Inventories | 270,597 | 254,122 | |||||
| Prepaid assets | 39,845 | 32,387 | |||||
| Other current assets | 4,345 | 3,764 | |||||
| Total current assets | 568,673 | 573,775 | |||||
| Property, plant and equipment, net | 401,701 | 411,591 | |||||
| Operating lease right-of-use assets | 179,221 | 154,866 | |||||
| Deferred tax assets | 2,959 | 2,706 | |||||
| 275,468 | 271,346 | ||||||
| Intangible assets, net | 544,323 | 549,137 | |||||
| Other assets | 5,818 | 4,812 | |||||
| Total assets | $ | 1,978,163 | $ | 1,968,233 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 116,095 | $ | 131,307 | |||
| Accrued liabilities | 77,325 | 95,155 | |||||
| Income taxes payable | 7,101 | 12,076 | |||||
| Current maturities of long-term debt | 28,566 | 27,561 | |||||
| Current operating lease liabilities | 16,749 | 15,446 | |||||
| Total current liabilities | 245,836 | 281,545 | |||||
| Long-term debt | 678,636 | 665,268 | |||||
| Noncurrent operating lease liabilities | 168,668 | 145,459 | |||||
| Deferred income taxes | 139,804 | 135,993 | |||||
| Other liabilities | 14,865 | 13,789 | |||||
| Total liabilities | 1,247,809 | 1,242,054 | |||||
| Stockholders’ equity: | |||||||
| Common stock | 512 | 512 | |||||
| Additional paid-in-capital | 695,426 | 700,029 | |||||
| Retained earnings | 156,963 | 164,710 | |||||
| Accumulated other comprehensive loss | (24,329 | ) | (35,439 | ) | |||
| (98,218 | ) | (103,633 | ) | ||||
| Total stockholders’ equity | 730,354 | 726,179 | |||||
| Total liabilities and stockholders' equity | $ | 1,978,163 | $ | 1,968,233 | |||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (In thousands) (Unaudited) |
|||||||
| Three Months Ended |
|||||||
| 2026 |
2025 |
||||||
| Operating activities: | |||||||
| Net loss | $ | (4,071 | ) | $ | (14,885 | ) | |
| Adjustments to reconcile net loss to cash used for operating activities: | |||||||
| Depreciation and amortization | 24,249 | 24,740 | |||||
| Stock-based compensation | 1,166 | 902 | |||||
| Deferred income tax | 1,808 | 2,851 | |||||
| Other, net | 1,300 | 6,173 | |||||
| Changes in assets and liabilities: | |||||||
| Decrease in accounts receivable | 18,743 | 30,330 | |||||
| Increase in inventory | (13,669 | ) | (8,602 | ) | |||
| Increase in other current assets | (7,043 | ) | (8,985 | ) | |||
| Decrease in accounts payable | (13,982 | ) | (16,548 | ) | |||
| Decrease in accrued liabilities | (19,022 | ) | (22,558 | ) | |||
| Decrease in current income taxes payable | (5,203 | ) | (5,087 | ) | |||
| Other, net | (4,484 | ) | (841 | ) | |||
| Cash used for operating activities | (20,208 | ) | (12,510 | ) | |||
| Investing activities: | |||||||
| Capital expenditures | (11,294 | ) | (11,624 | ) | |||
| Proceeds from disposition of capital assets | 55 | 169 | |||||
| Cash used for investing activities | (11,239 | ) | (11,455 | ) | |||
| Financing activities: | |||||||
| Borrowings under credit facilities | 57,000 | 45,000 | |||||
| Repayments of credit facility borrowings | (36,250 | ) | (56,250 | ) | |||
| Repayments of other long-term debt | (838 | ) | (2,026 | ) | |||
| Common stock dividends paid | (3,638 | ) | (3,812 | ) | |||
| Issuance of common stock | - | 214 | |||||
| Payroll tax paid to settle shares forfeited upon vesting of stock | (354 | ) | (1,400 | ) | |||
| Purchase of treasury stock | - | (3,698 | ) | ||||
| Cash provided by (used for) financing activities | 15,920 | (21,972 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents | 2,052 | (1,590 | ) | ||||
| Decrease in cash, cash equivalents and restricted cash | (13,475 | ) | (47,527 | ) | |||
| Cash, cash equivalents and restricted cash at beginning of period | 78,118 | 102,995 | |||||
| Cash, cash equivalents and restricted cash at end of period | $ | 64,643 | $ | 55,468 | |||
FREE CASH FLOW AND NET DEBT RECONCILIATION (In thousands) (Unaudited) |
|||||||
| The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | |||||||
| Three Months Ended |
|||||||
| 2026 |
2025 |
||||||
| Cash used for operating activities | (20,208 | ) | (12,510 | ) | |||
| Capital expenditures | (11,294 | ) | (11,624 | ) | |||
| Free Cash Flow | (31,502 | ) | (24,134 | ) | |||
| The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | |||||||
| As of |
|||||||
| 2026 |
2025 |
||||||
| Term loan facility | $ | 462,500 | $ | 487,500 | |||
| Revolving credit facility | 199,500 | 217,500 | |||||
| Finance lease obligations (1) | 55,505 | 59,306 | |||||
| Total debt (2) | 717,505 | 764,306 | |||||
| Less: Cash and cash equivalents | 62,311 | 49,982 | |||||
| Net Debt | 655,194 | 714,324 | |||||
| (1) Includes |
|||||||
| (2) Excludes outstanding letters of credit. |
|||||||
NON-GAAP FINANCIAL MEASURE DISCLOSURE LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION (In thousands, except per share data) (Unaudited) |
|||||||||||||||||||
| Reconciliation of Last Twelve Months Adjusted EBITDA | Three Months Ended |
Three Months Ended |
Three Months Ended |
Three Months Ended |
Total | ||||||||||||||
| Reconciliation | Reconciliation | Reconciliation | Reconciliation | Reconciliation | |||||||||||||||
| Net (loss) income as reported | $ | (4,071 | ) | $ | 19,571 | $ | (276,007 | ) | $ | 20,515 | $ | (239,992 | ) | ||||||
| Income tax (benefit) expense | 173 | 15,147 | (8,191 | ) | 6,307 | 13,436 | |||||||||||||
| Other, net | (5,617 | ) | (5,246 | ) | (855 | ) | 159 | (11,559 | ) | ||||||||||
| Interest expense | 12,367 | 13,468 | 14,218 | 13,940 | 53,993 | ||||||||||||||
| Depreciation and amortization | 24,249 | 25,630 | 33,882 | 19,192 | 102,953 | ||||||||||||||
| Asset impairment charges | - | - | 302,284 | - | 302,284 | ||||||||||||||
| EBITDA | 27,101 | 68,570 | 65,331 | 60,113 | 221,115 | ||||||||||||||
| Cost of sales (1) | 407 | 308 | 148 | 976 | 1,839 | ||||||||||||||
| Selling, general and administrative (1),(2) | (126 | ) | 2,056 | 3,449 | 1,110 | 6,489 | |||||||||||||
| Restructuring (credit) charges (3) | - | (16 | ) | 1,367 | 936 | 2,287 | |||||||||||||
| Adjusted EBITDA | $ | 27,382 | $ | 70,918 | $ | 70,295 | $ | 63,135 | $ | 231,730 | |||||||||
| (1) Expense related to plant closure/relocation. |
|||||||||||||||||||
| (2) Transaction, advisory fees, reorganization costs and product recall expenses. |
|||||||||||||||||||
| (3) Restructuring (credit) charges related to severance. |
|||||||||||||||||||
NON-GAAP FINANCIAL MEASURE DISCLOSURE (In thousands, except per share data) (Unaudited) |
|||||||||||||||||
| Reconciliation of Adjusted Net Income and Adjusted EPS | Three Months Ended |
Three Months Ended |
|||||||||||||||
| Net Income | Diluted EPS | Net Income | Diluted EPS | ||||||||||||||
| Net loss as reported | $ | (4,071 | ) | $ | (0.09 | ) | $ | (14,885 | ) | $ | (0.32 | ) | |||||
| Net loss reconciling items from below | 3,801 | $ | 0.08 | 23,847 | $ | 0.51 | |||||||||||
| Adjusted net income and adjusted EPS | $ | (270 | ) | $ | (0.01 | ) | $ | 8,962 | $ | 0.19 | |||||||
| Reconciliation of Adjusted EBITDA | Three Months Ended |
Three Months Ended |
|||||||||||||||
| Reconciliation | Reconciliation | ||||||||||||||||
| Net loss as reported | $ | (4,071 | ) | $ | (14,885 | ) | |||||||||||
| Income tax benefit | 173 | (5,050 | ) | ||||||||||||||
| Other, net | (5,617 | ) | (1,229 | ) | |||||||||||||
| Interest expense | 12,367 | 14,186 | |||||||||||||||
| Depreciation and amortization | 24,249 | 24,740 | |||||||||||||||
| EBITDA | 27,101 | 17,762 | |||||||||||||||
| EBITDA reconciling items from below | 281 | 20,780 | |||||||||||||||
| Adjusted EBITDA | $ | 27,382 | $ | 38,542 | |||||||||||||
| Reconciling Items | Three Months Ended |
Three Months Ended |
|||||||||||||||
| Income Statement | Reconciling Items | Income Statement | Reconciling Items | ||||||||||||||
| Net sales | $ | 409,089 | $ | - | $ | 400,044 | $ | - | |||||||||
| Cost of sales | 310,562 | (407 | ) | (1) | 307,728 | (9,007 | ) | (2) | |||||||||
| Selling, general and administrative | 71,426 | 126 | (1),(3) | 66,650 | (3,869 | ) | (1),(3) | ||||||||||
| Restructuring charges | - | - | 7,904 | (7,904 | ) | (4) | |||||||||||
| EBITDA | 27,101 | 281 | 17,762 | 20,780 | |||||||||||||
| Depreciation and amortization | 24,249 | (9,757 | ) | (5) | 24,740 | (10,650 | ) | (5) | |||||||||
| Operating income (loss) | 2,852 | 10,038 | (6,978 | ) | 31,430 | ||||||||||||
| Interest expense | (12,367 | ) | - | (14,186 | ) | - | |||||||||||
| Other, net | 5,617 | (5,072 | ) | (6) | 1,229 | (172 | ) | (6) | |||||||||
| Loss before income taxes | (3,898 | ) | 4,966 | (19,935 | ) | 31,258 | |||||||||||
| Income tax benefit | (173 | ) | (1,165 | ) | (7) | 5,050 | (7,411 | ) | (7) | ||||||||
| Net loss | $ | (4,071 | ) | $ | 3,801 | $ | (14,885 | ) | $ | 23,847 | |||||||
| Diluted loss per share | $ | (0.09 | ) | $ | (0.32 | ) | |||||||||||
| (1) Expense related to plant closure/relocation. |
|||||||||||||||||
| (2) Amortization of step-up for purchase price adjustments on inventory. |
|||||||||||||||||
| (3) Transaction, advisory fees, reorganization costs and product recall expenses. |
|||||||||||||||||
| (4) Restructuring charges related to severance and disposal of software. |
|||||||||||||||||
| (5) Amortization expense related to intangible assets. |
|||||||||||||||||
| (6) Foreign currency transaction gains. |
|||||||||||||||||
| (7) Tax impact of net income reconciling items. |
|||||||||||||||||
SELECTED SEGMENT DATA (In thousands) (Unaudited) |
|||||||||||||||||||
| This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | |||||||||||||||||||
| Hardware Solutions | Extruded Solutions | Custom Solutions | Total | ||||||||||||||||
| Three months ended |
|||||||||||||||||||
| Net sales | $ | 189,112 | $ | 139,800 | $ | 89,142 | $ | (8,965 | ) | $ | 409,089 | ||||||||
| Cost of sales | 150,724 | 97,709 | 71,424 | (9,295 | ) | 310,562 | |||||||||||||
| Gross Margin | 38,388 | 42,091 | 17,718 | 330 | 98,527 | ||||||||||||||
| Gross Margin % | 20.3 | % | 30.1 | % | 19.9 | % | 24.1 | % | |||||||||||
| Selling, general and administrative (1) | 34,180 | 21,141 | 13,150 | 2,955 | 71,426 | ||||||||||||||
| Depreciation and amortization | 11,547 | 7,339 | 5,222 | 141 | 24,249 | ||||||||||||||
| Operating (loss) income | (7,339 | ) | 13,611 | (654 | ) | (2,766 | ) | 2,852 | |||||||||||
| Depreciation and amortization | 11,547 | 7,339 | 5,222 | 141 | 24,249 | ||||||||||||||
| EBITDA | 4,208 | 20,950 | 4,568 | (2,625 | ) | 27,101 | |||||||||||||
| Expense related to plant relocation (Cost of sales) | 407 | - | - | - | 407 | ||||||||||||||
| Credit related to plant relocation (SG&A) | (141 | ) | - | - | - | (141 | ) | ||||||||||||
| Transaction, advisory fees, reorganization costs, and product recall expenses | 70 | - | - | (55 | ) | 15 | |||||||||||||
| Adjusted EBITDA | $ | 4,544 | $ | 20,950 | $ | 4,568 | $ | (2,680 | ) | $ | 27,382 | ||||||||
| Adjusted EBITDA Margin % | 2.4 | % | 15.0 | % | 5.1 | % | 6.7 | % | |||||||||||
| Three months ended |
|||||||||||||||||||
| Net sales | $ | 184,740 | $ | 139,630 | $ | 85,038 | $ | (9,364 | ) | $ | 400,044 | ||||||||
| Cost of sales | 150,785 | 97,680 | 68,298 | (9,035 | ) | 307,728 | |||||||||||||
| Gross Margin | 33,955 | 41,950 | 16,740 | (329 | ) | 92,316 | |||||||||||||
| Gross Margin % | 18.4 | % | 30.0 | % | 19.7 | % | 23.1 | % | |||||||||||
| Selling, general and administrative (1) | 33,357 | 18,508 | 11,598 | 3,187 | 66,650 | ||||||||||||||
| Restructuring charges | 6,119 | - | - | 1,785 | 7,904 | ||||||||||||||
| Depreciation and amortization | 11,470 | 7,640 | 5,540 | 90 | 24,740 | ||||||||||||||
| Operating (loss) income | (16,991 | ) | 15,802 | (398 | ) | (5,391 | ) | (6,978 | ) | ||||||||||
| Depreciation and amortization | 11,470 | 7,640 | 5,540 | 90 | 24,740 | ||||||||||||||
| EBITDA | (5,521 | ) | 23,442 | 5,142 | (5,301 | ) | 17,762 | ||||||||||||
| Transaction, advisory fees, reorganization costs, and product recall expenses | 90 | 158 | - | 3,621 | 3,869 | ||||||||||||||
| Amortization of step-up for purchase price adjustments on inventory | 7,509 | 352 | 1,146 | - | 9,007 | ||||||||||||||
| Restructuring charges | 6,119 | - | - | 1,785 | 7,904 | ||||||||||||||
| Adjusted EBITDA | $ | 8,197 | $ | 23,952 | $ | 6,288 | $ | 105 | $ | 38,542 | |||||||||
| Adjusted EBITDA Margin % | 4.4 | % | 17.2 | % | 7.4 | % | 9.6 | % | |||||||||||
| (1) Includes stock-based compensation expense of |
|||||||||||||||||||
SELECTED SEGMENT DATA RECONCILIATION (In thousands) (Unaudited) |
||||||||||||||||||||||||
| This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated |
||||||||||||||||||||||||
| NA Fenestration | EU Fenestration | NA Cabinet Components | Tyman | Total | ||||||||||||||||||||
| Three months ended |
||||||||||||||||||||||||
| Net sales | $ | 134,333 | $ | 48,471 | $ | 43,810 | $ | 175,676 | $ | (2,246 | ) | $ | 400,044 | |||||||||||
| Cost of sales | 106,567 | 30,638 | 39,415 | 132,796 | (1,688 | ) | 307,728 | |||||||||||||||||
| Gross Margin | 27,766 | 17,833 | 4,395 | 42,880 | (558 | ) | 92,316 | |||||||||||||||||
| Gross Margin % | 20.7 | % | 36.8 | % | 10.0 | % | 24.4 | % | 23.1 | % | ||||||||||||||
| Selling, general and administrative | 16,133 | 7,920 | 5,268 | 34,378 | 2,951 | 66,650 | ||||||||||||||||||
| Restructuring charges | - | - | - | 7,904 | - | 7,904 | ||||||||||||||||||
| Depreciation and amortization | 4,779 | 2,610 | 3,009 | 14,263 | 79 | 24,740 | ||||||||||||||||||
| Operating income (loss) | 6,854 | 7,303 | (3,882 | ) | (13,665 | ) | (3,588 | ) | (6,978 | ) | ||||||||||||||
| Depreciation and amortization | 4,779 | 2,610 | 3,009 | 14,263 | 79 | 24,740 | ||||||||||||||||||
| EBITDA | 11,633 | 9,913 | (873 | ) | 598 | (3,509 | ) | 17,762 | ||||||||||||||||
| Amortization of step-up for purchase price adjustments on inventory | - | - | - | 9,007 | - | 9,007 | ||||||||||||||||||
| Transaction and advisory fees | - | - | - | 1,469 | 2,400 | 3,869 | ||||||||||||||||||
| Restructuring charges | 7,904 | - | 7,904 | |||||||||||||||||||||
| Adjusted EBITDA | $ | 11,633 | $ | 9,913 | $ | (873 | ) | $ | 18,978 | $ | (1,109 | ) | $ | 38,542 | ||||||||||
| Adjusted EBITDA Margin % | 8.7 | % | 20.5 | % | -2.0 | % | 10.8 | % | 9.6 | % | ||||||||||||||
| Hardware Solutions(1) | Extruded Solutions(2) | Custom Solutions(3) | Tyman | Total | ||||||||||||||||||||
| Three months ended |
||||||||||||||||||||||||
| Net sales | $ | 184,740 | $ | 139,630 | $ | 85,038 | $ | - | $ | (9,364 | ) | $ | 400,044 | |||||||||||
| Cost of sales | 150,785 | 97,680 | 68,298 | - | (9,035 | ) | 307,728 | |||||||||||||||||
| Gross Margin | 33,955 | 41,950 | 16,740 | - | (329 | ) | 92,316 | |||||||||||||||||
| Gross Margin % | 18.4 | % | 30.0 | % | 19.7 | % | 23.1 | % | ||||||||||||||||
| Selling, general and administrative | 33,357 | 18,508 | 11,598 | 3,187 | 66,650 | |||||||||||||||||||
| Restructuring charges | 6,119 | - | - | - | 1,785 | 7,904 | ||||||||||||||||||
| Depreciation and amortization | 11,470 | 7,640 | 5,540 | - | 90 | 24,740 | ||||||||||||||||||
| Operating (loss) income | (16,991 | ) | 15,802 | (398 | ) | - | (5,391 | ) | (6,978 | ) | ||||||||||||||
| Depreciation and amortization | 11,470 | 7,640 | 5,540 | - | 90 | 24,740 | ||||||||||||||||||
| EBITDA | (5,521 | ) | 23,442 | 5,142 | - | (5,301 | ) | 17,762 | ||||||||||||||||
| Reorganization costs (SG&A) | 2,400 | 2,400 | ||||||||||||||||||||||
| Amortization of step-up for purchase price adjustments on inventory | 7,509 | 352 | 1,146 | - | - | 9,007 | ||||||||||||||||||
| Transaction and advisory fees | 90 | 158 | - | - | 1,221 | 1,469 | ||||||||||||||||||
| Restructuring charges | 6,119 | 1,785 | 7,904 | |||||||||||||||||||||
| Adjusted EBITDA | $ | 8,197 | $ | 23,952 | $ | 6,288 | $ | - | $ | 105 | $ | 38,542 | ||||||||||||
| Adjusted EBITDA Margin % | 4.4 | % | 17.2 | % | 7.4 | % | 9.6 | % | ||||||||||||||||
| (1) Contains a portion of the previously reported NA Fenestration segment. |
||||||||||||||||||||||||
| (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. |
||||||||||||||||||||||||
| (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. |
||||||||||||||||||||||||
SALES ANALYSIS (In thousands) (Unaudited) |
||||||||
| Three Months Ended |
||||||||
| 2026 |
2025 |
|||||||
| Hardware Solutions:(1) | ||||||||
| Window and door hardware | $ | 124,701 | $ | 122,353 | ||||
| Screens | 62,599 | 60,554 | ||||||
| Other | 1,812 | 1,833 | ||||||
| $ | 189,112 | $ | 184,740 | |||||
| Extruded Solutions:(2) | ||||||||
| Window profiles | $ | 58,355 | $ | 59,845 | ||||
| Seals and gaskets | 17,634 | 18,041 | ||||||
| Spacers | 47,602 | 42,861 | ||||||
| Solar | 4,605 | 5,523 | ||||||
| Flashing Tape | 1,518 | 2,114 | ||||||
| Window and door hardware | 7,512 | 9,458 | ||||||
| Other | 2,574 | 1,788 | ||||||
| $ | 139,800 | $ | 139,630 | |||||
| Custom Solutions:(3) | ||||||||
| Wood solutions | $ | 46,654 | $ | 43,810 | ||||
| Access solutions | 23,045 | 22,908 | ||||||
| Mixing solutions | 19,443 | 18,320 | ||||||
| $ | 89,142 | $ | 85,038 | |||||
| Unallocated Corporate & Other: | ||||||||
| Eliminations | $ | (8,965 | ) | $ | (9,364 | ) | ||
| $ | (8,965 | ) | $ | (9,364 | ) | |||
| $ | 409,089 | $ | 400,044 | |||||
| (1) Reflects an increase of |
||||||||
| (2) Reflects an increase of |
||||||||
| (3) Reflects an increase of |
||||||||
Source: Quanex Building Products Corporation